A New Era in Urticaria Treatment

In this episode of “All Things Urticaria” — a podcast from UCARE, the Global Allergy and Asthma Excellence Network — Prof. Torsten Zuberbier and Prof. Ana Giménez-Arnau discuss the newly released international urticaria guidelines. Developed with contributions from more than 100 societies and hundreds of experts worldwide, these guidelines represent a major step forward in the management of chronic spontaneous urticaria (CSU).


They discuss:

🔹 What makes the new urticaria guidelines more flexible than previous versions?

🔹 How has the treatment algorithm evolved beyond antihistamines and omalizumab?

🔹 What role do new therapies like remibrutinib and dupilumab play?

🔹 How can physicians choose the right treatment based on patient characteristics and comorbidities?

🔹 Why is early treatment escalation important for achieving disease control?

🔹 What does “assess and act” mean in daily clinical practice?


The episode highlights a shift toward individualized treatment decisions, shared decision-making with patients, and the integration of new therapeutic options. With a stronger focus on flexibility and real-world applicability, the new guidelines aim to improve outcomes for urticaria patients worldwide.


Key Learnings from the Episode:

The new urticaria guidelines are more flexible than previous versions.

Treatment decisions can now be individualized based on patient needs.

New therapies such as remibrutinib and dupilumab expand treatment options.

Omalizumab remains an important and well-established therapy.

Early escalation of treatment is key when antihistamines fail.

Combination therapies are now possible in certain cases.

Comorbidities should guide treatment choice.

Patient-reported outcomes are essential for disease management.

Tools like the CRUSE app support monitoring and decision-making.

“Assess and act” is a central principle in modern urticaria care.


Chapters:

00:00 Introduction to New Guidelines on Urticaria

03:35 Flexibility in Treatment Options

06:21 Understanding Non-Response and Treatment Decisions

09:08 Choosing the Right Treatment for Urticaria

12:00 Patient-Centered Care and Communication

14:37 Conclusion and Future Directions


Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.

Feedback form: ATU: ⁠⁠⁠⁠⁠⁠⁠⁠https://forms.office.com/e/m6a2uEdsUH

Episoder(119)

Managing Urticaria in Resource-Limited Settings

Managing Urticaria in Resource-Limited Settings

In this episode of the UCARE Global Allergy and Asthma Excellence Network podcast on Urticaria, Prof. Torsten Zuberbier speaks with Dr. Emma Kruger from Cape Town, South Africa, about managing urticar...

24 Mar 17min

Drug Survival of Omalizumab

Drug Survival of Omalizumab

In this episode of the Urticaria podcast series, Prof. Torsten Zuberbier speaks with Reineke Soegiharto, PhD candidate and dermatology resident from UMC Utrecht, about the international UCARE study DR...

24 Feb 17min

Visualizing Urticaria Worldwide

Visualizing Urticaria Worldwide

In this episode of the GA²LEN Urticaria Podcast, Professor Torsten Zuberbier is joined by Professor Simon Francis Thomsen from Denmark to introduce an exciting new global initiative within the UCARE n...

28 Jan 19min

A New Era for Urticaria Treatment

A New Era for Urticaria Treatment

In this short, conference-based episode, Professor Torsten Zuberbier, President of Global Allergy and Asthma Excellence Network, speaks with Professor Kiran Godse from Mumbai, India, directly from the...

18 Des 20255min

Measuring What Matters: PROMs in Urticaria Care

Measuring What Matters: PROMs in Urticaria Care

In this episode of the GA²LEN (Global Allergy and Asthma Excellence Network) Podcast on Everything Urticaria, Professor Torsten Zuberbier talks with Dr. Karsten Weller, a leading expert and developer ...

2 Des 202519min

Why Do Hives Look the Way They Do?

Why Do Hives Look the Way They Do?

In this episode of the GA²LEN (Global Allergy and Asthma Excellence Network) Podcast on Everything Urticaria, Professor Torsten Zuberbier speaks with Professor Michihiro Hide from Hiroshima, Japan — a...

28 Okt 202521min

UDAY & New Guidelines: Empowering Patients Worldwide

UDAY & New Guidelines: Empowering Patients Worldwide

In this episode, Prof. Torsten Zuberbier (Global Allergy and Asthma Excellence Network President) welcomes Prof. Petra Staubach, urticaria expert from Germany, to talk about Urticaria Day (UDAY) — hel...

30 Sep 202517min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
liberal-halvtime
forskningno
rekommandert
sinnsyn
rss-paradigmepodden
tomprat-med-gunnar-tjomlid
villmarksliv
rss-overskuddsliv
fjellsportpodden
kvinnehelsepodden
rss-nysgjerrige-norge
tidlose-historier
nevropodden
rss-inn-til-kjernen-med-sunniva-rose
dekodet-2
nordnorsk-historie
rss-rekommandert